Neurogastrx

Developer of a dopamine receptor antagonist to treat gastrointestinal disorders

placeCampbell, California, United States calendar_todayFounded 2012 groups13 employees language neurogastrx.com

Registered entities

Social engagement

Social engagement: 1.1K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include 5AM Ventures, Orbimed, VenBio, Vivo Capital.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%

Recent activity

28 Oct 2025
Event
The Obesity Society's ObesityWeek
7 Oct 2025
Event
ObesityWeek®
Coming soon